These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 17332308

  • 1. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas.
    Siddiqui IA, Zaman N, Aziz MH, Reagan-Shaw SR, Sarfaraz S, Adhami VM, Ahmad N, Raisuddin S, Mukhtar H.
    Carcinogenesis; 2006 Apr 08; 27(4):833-9. PubMed ID: 16387739
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.
    Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H.
    Cancer Res; 1999 May 01; 59(9):2115-20. PubMed ID: 10232597
    [Abstract] [Full Text] [Related]

  • 5. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 6. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar 15; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 7. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ.
    Mol Carcinog; 2006 May 15; 45(5):309-19. PubMed ID: 16508969
    [Abstract] [Full Text] [Related]

  • 8. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene.
    Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H.
    Int J Cancer; 2006 Jul 01; 119(1):33-40. PubMed ID: 16463383
    [Abstract] [Full Text] [Related]

  • 9. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H.
    Oncogene; 2008 Mar 27; 27(14):2055-63. PubMed ID: 17998943
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 11. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H.
    Cancer Res; 2005 Dec 01; 65(23):11203-13. PubMed ID: 16322271
    [Abstract] [Full Text] [Related]

  • 12. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA.
    Prostate; 2007 Oct 01; 67(14):1576-89. PubMed ID: 17705241
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 14. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
    Schroeder CP, Kadara H, Lotan D, Woo JK, Lee HY, Hong WK, Lotan R.
    Cancer Res; 2006 Oct 01; 66(19):9762-70. PubMed ID: 17018636
    [Abstract] [Full Text] [Related]

  • 15. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb 15; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 17. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC.
    Nutr Cancer; 2008 Feb 15; 60(4):483-91. PubMed ID: 18584482
    [Abstract] [Full Text] [Related]

  • 18. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [Abstract] [Full Text] [Related]

  • 19. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA, Reddy BS, Bosland MC, Nargi D, Horton L, Randolph C, Narayanan NK.
    Clin Cancer Res; 2007 Oct 01; 13(19):5965-73. PubMed ID: 17908994
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4865-73. PubMed ID: 15269163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.